Treating the Orthopedic Manifestations of Metabolic Disease (Not the Disease Itself)

Last January I stood in front of the residents and faculty at the University of Miami and laid out what I’ve been seeing in my hand and microvascular practice for the last decade.

Here’s the bottom line, and it’s the same one I give every patient and every trainee:

I treat the orthopedic manifestations of metabolic disease. I do not treat the metabolic disease itself.

Think trauma surgery. When the femur is shattered, the trauma team doesn’t chase the drunk driver or rebuild the car. They stabilize the bone, restore blood flow, and get the patient moving again. Same here. My patients show up with painful diabetic neuropathy, recalcitrant tendinopathy, frozen shoulders, or non-healing wounds. Those are the problems I fix — with surgery when needed, and with metabolic optimization when it actually moves the needle on healing. I leave the insulin resistance, the A1c, and the endocrinology to the people trained for it.

During Grand Rounds I walked through three real-world patterns I see every week (all cases de-identified, of course):

  1. The distal humerus fracture that used to take me four hours and still left me sweating. The book said interdigitating non-locking screws, but I developed a tie-beam technique (ACL guide, over-drill, compress the articular surface first) that turns the dreaded C-type into a simple A-type block. One small innovation and the construct is rock-solid.

  2. The cubital tunnel patient who failed the “standard” short release. The book told us the nerve only needs decompression at the elbow; we now know the Arcade of Struthers is real and the FCU pedicles pinch farther than most realize. Using a facelift scope I can get a true long decompression — pale nerve turns pink right in front of you — and patients wake up dramatically better.

  3. The tennis-elbow or golfer’s-elbow patient who’s had every injection and therapy under the sun. The book says “conservative care or open debridement.” I use ultrasound tenotomy (Tenex) to remove the bad tendon tissue exactly like cataract phaco — same problem at every enthesis. Pain gone, function back, no big scar.

The data I presented is straightforward: patients with uncontrolled metabolic disease have 2–3× higher rates of infection, non-union, and stiffness after elective hand/upper-extremity surgery. But when we address the orthopedic problem directly and layer in simple, evidence-based metabolic tweaks (protein timing, anti-inflammatory eating, sleep), outcomes jump.

That’s where #SurgicalEmpathy comes in.

Most surgeons think empathy is soft. I think it’s tactical and precise. It’s the 90-second pause where you actually listen to the patient describe what “my hand just doesn’t work anymore” really means to them. That single moment changes your differential, sharpens your exam, and often sparks the innovative solution that textbooks don’t cover. I call it Surgical Empathy because it happens with a scalpel in your hand and a clock on the wall — and it makes you a better technician, not a softer one.

In the talk I shared the three-question framework I now teach residents:

  • What is the patient’s real functional loss? (Not the MRI.)

  • How does their metabolic picture change the healing timeline?

  • What one small innovation can I add today that respects both?

If you’re a surgeon, resident, or therapist reading this: the orthopedic manifestations are your playground. Treat them aggressively and well. Optimize the metabolic side without pretending you’re an endocrinologist. And never underestimate how 60 seconds of real listening can turn a good operation into a great outcome.

Drop a comment below or DM me with the toughest metabolic ortho case you’re seeing right now. I read every one. Full slide deck from UMiami Grand Rounds available on request.

— Rob Gray, MD